Bladder Neck Contracture
Conditions
Interventions
Transurethral Resection of the Prostate Group:None
Photoselective Vaporization of the Prostate Group:None
Holmium Laser Enucleation of the Prostate Group:None
Sponsors
Zhejiang Provincial People's Hospital
Eligibility
Sex/Gender
Male
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Age >= 18 years old, male; 2.Patients are clinically diagnosed with benign prostatic hyperplasia (BPH) in accordance with the diagnostic criteria established by the Chinese Urological Association BPH Guidelines. The main criteria are as follows: Lower urinary tract symptoms (LUTS) consistent with typical BPH presentation, such as weak urinary stream, nocturia, urinary frequency, and urgency; Imaging findings (ultrasound or MRI) indicating prostate enlargement; PSA test not suggesting a high risk of malignancy, or prostate cancer has been ruled out; 3.Preoperative imaging evaluation (e.g., transabdominal or transrectal ultrasound, elastography) has been performed with clear image quality; 4.Agree to collect preoperative blood and urine samples for subsequent molecular marker research; 5.Planned to receive surgical intervention treatments (such as TURP, green laser PVP, HoLEP, water jet vaporization, etc.); 6.It has complete preoperative clinical assessment data, including IPSS, Qmax, residual urine volume and prostate "Product, PSA, etc."; 7.Have the ability to sign informed consent and voluntarily participate in this research.
Exclusion criteria
Exclusion criteria: 1.Patients with confirmed or suspected prostate cancer (e.g., biopsy indicating adenocarcinoma or elevated PSA without definitive exclusion of malignancy); 2.Patients with a history of prior prostate-related surgical treatments (e.g., TURP, PVP, HoLEP, etc.); 3.Patients with severe organ dysfunction (e.g., liver or renal failure), active infections, immune system disorders, or psychiatric illnesses; 4.Patients who are unable to provide essential preoperative or intraoperative data (e.g., imaging records, surgical parameters) or tissue samples; 5.Patients who refuse to participate or are unable to comply with study procedures and follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| International Prostate Symptom Score;Post-Void Residual Volume;Maximum Urinary Flow Rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Prostate Volume;Perioperative Complications; | — |
Countries
China
Contacts
Public ContactQi Zhang
Zhejiang Provincial People's Hospital
Outcome results
None listed